MNPR icon

Monopar Therapeutics

13 hedge funds and large institutions have $1.21M invested in Monopar Therapeutics in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+6
Holders Change %
+85.71%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Marshall Wace
1
Marshall Wace
United Kingdom
$295K +$295K +9,531 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$279K +$279K +9,014 New
Northern Trust
3
Northern Trust
Illinois
$223K -$141K -4,559 -39%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$163K +$163K +5,279 New
Citadel Advisors
5
Citadel Advisors
Florida
$77K +$77K +2,496 New
BlackRock
6
BlackRock
New York
$70K +$36.4K +1,168 +108%
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$57K +$57K +1,826 New
Morgan Stanley
8
Morgan Stanley
New York
$20K
TRCT
9
Tower Research Capital (TRC)
New York
$14K +$5.1K +161 +57%
APA
10
American Portfolios Advisors
New York
$4.34K +$4.34K +140 New
UBS Group
11
UBS Group
Switzerland
$4K -$2.67K -76 -40%
CAPTRUST Financial Advisors
12
CAPTRUST Financial Advisors
North Carolina
$1K